The Discounted Cash Flow (DCF) valuation of Novocure Ltd (NVCR) is (35.25) USD. With the latest stock price at 12.15 USD, the upside of Novocure Ltd based on DCF is -390.1%.
Based on the latest price of 12.15 USD and our DCF valuation, Novocure Ltd (NVCR) is a sell. selling Novocure stocks now will result in a potential gain of 390.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
WACC / Discount Rate | 6.1% - 8.9% | 7.5% |
Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
Fair Price | (96.28) - (23.64) | (35.25) |
Upside | -892.4% - -294.6% | -390.1% |